Abstract
The effects of the tested factors including pH value, NaCl concentration, ODN concentration and charge ratio on the size and zeta potentials of nanoparticles (ODN-PLL, PLL: poly(l-lysine)s) were investigated by use of uniform design and NGR peptides were used to modify the nanoparticles, indicating that none of the tested factors was correlated with nanoparticles size, however, a linear correlation (r = 0.8505) was found between charge ratio and zeta potential. A nanosize delivery system (ODN-PLL-NGR) with the function of targeting to tumor cells was developed by use of PLL to condense oligonucleotide into nanoparticles coated with peptide containing NGR motif. The ODN-PLL-NGR had the ability to protect ODN against nuclease degradation, and its cell uptake increased with time increment after incubation at 37°C for 40, 50 and 60 min.
Keywords: Nanosize delivery system, Poly(l-lysine)s, tumor cells, NGR
Current Nanoscience
Title: Investigation of the Oligonucleotide Nanosize Delivery System with the Function of Targeting to Tumor Cells
Volume: 4 Issue: 3
Author(s): Zhen Zhang, Xu Song, Baiyan Wang and Huixiang Li
Affiliation:
Keywords: Nanosize delivery system, Poly(l-lysine)s, tumor cells, NGR
Abstract: The effects of the tested factors including pH value, NaCl concentration, ODN concentration and charge ratio on the size and zeta potentials of nanoparticles (ODN-PLL, PLL: poly(l-lysine)s) were investigated by use of uniform design and NGR peptides were used to modify the nanoparticles, indicating that none of the tested factors was correlated with nanoparticles size, however, a linear correlation (r = 0.8505) was found between charge ratio and zeta potential. A nanosize delivery system (ODN-PLL-NGR) with the function of targeting to tumor cells was developed by use of PLL to condense oligonucleotide into nanoparticles coated with peptide containing NGR motif. The ODN-PLL-NGR had the ability to protect ODN against nuclease degradation, and its cell uptake increased with time increment after incubation at 37°C for 40, 50 and 60 min.
Export Options
About this article
Cite this article as:
Zhang Zhen, Song Xu, Wang Baiyan and Li Huixiang, Investigation of the Oligonucleotide Nanosize Delivery System with the Function of Targeting to Tumor Cells, Current Nanoscience 2008; 4 (3) . https://dx.doi.org/10.2174/157341308785161091
DOI https://dx.doi.org/10.2174/157341308785161091 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inflammatory and Non-Inflammatory Roles for Toll-Like Receptors in Gastrointestinal Cancer
Current Pharmaceutical Design A Co-Module Regulated by Therapeutic Drugs in a Molecular Subnetwork of Alzheimer’s Disease Identified on the Basis of Traditional Chinese Medicine and SAMP8 Mice
Current Alzheimer Research HPV as a Model for the Development of Prophylactic and Therapeutic Cancer Vaccines
Current Molecular Medicine Emerging Role of Circular RNAs in Kidney Diseases in Nephrology
Current Drug Targets An Overview on Keratinocyte Growth Factor: From the Molecular Properties to Clinical Applications
Protein & Peptide Letters MiR-125b Inhibits Cell Proliferation and Induces Apoptosis in Human Colon Cancer SW480 Cells <i>via</i> Targeting STAT3
Recent Patents on Anti-Cancer Drug Discovery Kruppel-Like Factors 4 and 5: Unity in Diversity
Current Genomics Nanocarriers in Improving Chemotherapy of Multidrug Resistant Tumors: Key Developments and Perspectives
Current Pharmaceutical Design The Immunohistochemical Expression of the E-Cadherin, Alpha-Catenin,Beta-Catenin and Gamma Catenin Proteins in Epithelial Ovarian Tumours: Relationship with Clinicopathologic Parameters and Patient Survival
Current Women`s Health Reviews Blockade of Insulin-Like Growth Factor Type-1 Receptor with Cixutumumab (IMC-A12): A Novel Approach to Treatment for Multiple Cancers
Current Drug Targets Pharmacogenetics, Pharmacogenomics and Epigenetics of Nrf2-regulated Xenobioticmetabolizing Enzymes and Transporters by Dietary Phytochemical and Cancer Chemoprevention
Current Drug Metabolism Genetic and Epigenetic Studies for Determining Molecular Targets of Natural Product Anticancer Agents
Current Cancer Drug Targets Silver and Other Metals in the Treatment of Gastrointestinal Diseases
Current Medicinal Chemistry The Caveolin-1 Connection to Cell Death and Survival
Current Molecular Medicine Therapeutic Hypothermia as a Neuroprotective Strategy in Neonatal Hypoxic-Ischemic Brain Injury and Traumatic Brain Injury
Current Molecular Medicine Auraptene: A Natural Biologically Active Compound with Multiple Targets
Current Drug Targets Impact of Oncogenic Protein Tyrosine Phosphatases in Cancer
Anti-Cancer Agents in Medicinal Chemistry Drug-Eluting Stents: Present and Future
Cardiovascular & Hematological Agents in Medicinal Chemistry Tea (Camellia sinensis (L.)): A Putative Anticancer Agent in Bladder Carcinoma?
Anti-Cancer Agents in Medicinal Chemistry Retinoid Related Molecules an Emerging Class of Apoptotic Agents with Promising Therapeutic Potential in Oncology: Pharmacological Activity and Mechanisms of Action
Current Pharmaceutical Design